Sunil Gupta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sunil Gupta has a total of 380 co-authors. Here are the top co-authors by number of shared publications:
- Michael J. Bourke
Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney 2145, Australia
26 shared publications - Nicholas Graeme Burgess
Westmead Hospital, New South Wales, Australia
23 shared publications Anthony Whitfield
Department of Gastroenterology and Hepatology Westmead Hospital Sydney New South Wales Australia
16 shared publicationsMichael J. Bourke
12 shared publicationsOliver Cronin
Westmead Hospital, New South Wales, Australia
12 shared publicationsClarence Kerrison
Department of Gastroenterology and Hepatology Westmead Hospital Sydney New South Wales Australia
10 shared publications
Latest Publications
- Open Access
- 27 August 2026
- Published by S. Karger AG in GE - Portuguese Journal of Gastroenterology
Risk of residual neoplasia after a Non-Curative Endoscopic Submucosal Dissection for Barrett’s esophagus neoplasia: a multinational study
Introduction: Endoscopic submucosal dissection (ESD) is one of the most important endoscopic techniques for the treatment of esophagus neoplasia. ESD is technically demanding, and therefore a significant rate of non-curative procedures is expected. Our goal was to assess the rate of residual lesion in the surgical specimen or during the endoscopic follow-up after a non-curative ESD performed for Barrett’s neoplasia. Methods: Multicenter analysis of all ESDs performed for Barrett’s neoplasia. Patients with non-curative ESDs who had been submitted to complementary surgery or had at least one follow-up endoscopy were included. Results: One hundred and forty-six non-curative ESDs (NC-ESD) in Barrett’s neoplasia were identified: 127 (87%) high-risk resections (HRR) and 19 (13%) local risk resections. The most common criterion for a HRR was deep submucosal invasion (93/127, 73%). Residual lesion was observed in 50 (34%) patients overall. Surgery was performed in 52 patients, and 54% of those had residual lesion in the wall or in the lymph nodes. LNM was found in deep submucosal invasive cancers only (9 in surgical specimens, 5 in the follow-up), and no independent risk factors to the presence of LNM were identified. Eleven patients (8%) showed disease progression in the follow-up. Conclusions: Our study showed a high rate of residual lesion after a surgery performed for a NC-ESD. Prospective, long-term and multinational studies are warranted to address the real risk of the classical high-risk criteria for LNM in the setting of Barrett’s neoplasia treated with ESD.
- 27 August 2026
- Published by S. Karger AG in GE - Portuguese Journal of Gastroenterology
Open AccessRisk of residual neoplasia after a Non-Curative Endoscopic Submucosal Dissection for Barrett’s esophagus neoplasia: a multinational study
Introduction: Endoscopic submucosal dissection (ESD) is one of the most important endoscopic techniques for the treatment of esophagus neoplasia. ESD is technically demanding, and therefore a significant rate of non-curative procedures is expected. Our goal was to assess the rate of residual lesion in the surgical specimen or during the endoscopic follow-up after a non-curative ESD performed for Barrett’s neoplasia. Methods: Multicenter analysis of all ESDs performed for Barrett’s neoplasia. Patients with non-curative ESDs who had been submitted to complementary surgery or had at least one follow-up endoscopy were included. Results: One hundred and forty-six non-curative ESDs (NC-ESD) in Barrett’s neoplasia were identified: 127 (87%) high-risk resections (HRR) and 19 (13%) local risk resections. The most common criterion for a HRR was deep submucosal invasion (93/127, 73%). Residual lesion was observed in 50 (34%) patients overall. Surgery was performed in 52 patients, and 54% of those had residual lesion in the wall or in the lymph nodes. LNM was found in deep submucosal invasive cancers only (9 in surgical specimens, 5 in the follow-up), and no independent risk factors to the presence of LNM were identified. Eleven patients (8%) showed disease progression in the follow-up. Conclusions: Our study showed a high rate of residual lesion after a surgery performed for a NC-ESD. Prospective, long-term and multinational studies are warranted to address the real risk of the classical high-risk criteria for LNM in the setting of Barrett’s neoplasia treated with ESD.
- 24 August 2026
- Published by Georg Thieme Verlag KG in Endoscopy
Prophylactic clip closure after right-colon endoscopic mucosal resection in a matched cohort of 470 patients exhibits subsite heterogeneity
Clinically significant post-endoscopic mucosal resection (EMR) bleeding (CSPEB) is the most common adverse event after EMR of large nonpedunculated colorectal polyps (LNPCPs). Randomized trials of prophylactic through-the-scope (TTS) clip closure have produced conflicting results, and it remains unclear whether the effect is uniform across right-colon subsites and whether complete apposition is required. We examined real-world outcomes of a universal right-colon clipping policy, with attention given to subsite heterogeneity and closure completeness. Consecutive patients who underwent EMR of right-sided LNPCPs ≥20 mm (January 2020–October 2025) with prophylactic TTS clip closure were identified from the prospectively maintained ACE (Australian Colonic Endoscopic resection) registry, and matched 1:1 by propensity score to a no-clip comparator from the same registry (pre-2020). The primary end point was CSPEB within 14 days; subsite heterogeneity and closure completeness were exploratory analyses. Propensity score matching yielded 235 matched pairs (n = 470), who were well balanced on all covariates. CSPEB occurred in 8/235 clipped (3.4%) versus 26/235 unclipped patients (11.1%; relative risk 0.31, 95%CI 0.14–0.66; number needed to treat 13; P = 0.002). Exploratory subsite analyses suggested benefit concentrated at the hepatic flexure (0% vs. 17.2%; P = 0.02) and ascending colon (2.0% vs. 10.1%; P = 0.03), with a nonsignificant difference at the cecum (8.2% vs. 13.7%; P = 0.43). Within the clipped cohort, CSPEB rates were similar with complete (5/143; 3.5%) and partial (3/92; 3.3%) closure (P > 0.99). In this single-center analysis, TTS clip closure was associated with lower CSPEB after right-colon EMR, especially at the hepatic flexure and ascending colon; partial apposition appeared as effective as complete closure. These hypothesis-generating observations warrant prospective evaluation.
- 24 August 2026
- Published by Georg Thieme Verlag KG in Endoscopy
Prophylactic clip closure after right-colon endoscopic mucosal resection in a matched cohort of 470 patients exhibits subsite heterogeneity
Clinically significant post-endoscopic mucosal resection (EMR) bleeding (CSPEB) is the most common adverse event after EMR of large nonpedunculated colorectal polyps (LNPCPs). Randomized trials of prophylactic through-the-scope (TTS) clip closure have produced conflicting results, and it remains unclear whether the effect is uniform across right-colon subsites and whether complete apposition is required. We examined real-world outcomes of a universal right-colon clipping policy, with attention given to subsite heterogeneity and closure completeness. Consecutive patients who underwent EMR of right-sided LNPCPs ≥20 mm (January 2020–October 2025) with prophylactic TTS clip closure were identified from the prospectively maintained ACE (Australian Colonic Endoscopic resection) registry, and matched 1:1 by propensity score to a no-clip comparator from the same registry (pre-2020). The primary end point was CSPEB within 14 days; subsite heterogeneity and closure completeness were exploratory analyses. Propensity score matching yielded 235 matched pairs (n = 470), who were well balanced on all covariates. CSPEB occurred in 8/235 clipped (3.4%) versus 26/235 unclipped patients (11.1%; relative risk 0.31, 95%CI 0.14–0.66; number needed to treat 13; P = 0.002). Exploratory subsite analyses suggested benefit concentrated at the hepatic flexure (0% vs. 17.2%; P = 0.02) and ascending colon (2.0% vs. 10.1%; P = 0.03), with a nonsignificant difference at the cecum (8.2% vs. 13.7%; P = 0.43). Within the clipped cohort, CSPEB rates were similar with complete (5/143; 3.5%) and partial (3/92; 3.3%) closure (P > 0.99). In this single-center analysis, TTS clip closure was associated with lower CSPEB after right-colon EMR, especially at the hepatic flexure and ascending colon; partial apposition appeared as effective as complete closure. These hypothesis-generating observations warrant prospective evaluation.
- 21 August 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (09) , 1064-1065
Perforation after colorectal endoscopic submucosal dissection – closable is not safe!
- 21 August 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (09) , 1064-1065
Perforation after colorectal endoscopic submucosal dissection – closable is not safe!
- 16 August 2026
- Published by Wiley in Internal Medicine Journal
Sustained clinical outcomes at long‐term follow‐up after peroral endoscopic myotomy for achalasia: a multicentre cohort study
Background: Peroral endoscopic myotomy (POEM) is an established treatment for achalasia, achieving >90% short‐term clinical success. However, long‐term durability remains less clear. This study evaluates POEM outcomes beyond 5 years in a multi‐centre cohort. Aims: This study evaluates POEM outcomes beyond 5 years in a multi‐centre cohort. Methods: Patients with achalasia who underwent POEM across four Australian tertiary centres (January 2014–January 2020) were prospectively enrolled. Eckardt scores were recorded pre‐treatment and at multiple intervals up to ≥5 years after POEM. Primary outcome was clinical success at ≥5 years, defined as Eckardt score ≤3 without need for re‐intervention. Secondary outcomes included risk factors for failure and management strategies. Results: Of 221 eligible patients, 153 (69.2%) had ≥5‐year follow‐up data available, with median follow‐up of 6.5 years (interquartile range (IQR) 5.6–7.6). Achalasia subtypes included type I (23.5%), type II (62.1%) and type III (14.4%). Among the patients, 52.3% were treatment‐naïve; prior therapies included laparoscopic Heller myotomy (14.3%), botulinum toxin (17.0%) and pneumatic balloon dilation (30.7%). Clinical success at ≥5 years was observed in 118 (77.1%) patients. Median Eckardt scores improved from 8.0 (IQR 6.0–10.0) before POEM to 0.0 (IQR 0.0–1.0) at 3–6 months, 1.0 (IQR 0.0–2.0) at 2 years and 2.0 (IQR 0.0–3.0) at 5 years. Sustained success was associated with lower baseline Eckardt scores ( P = 0.033). Prior lower oesophageal sphincter (LOS)‐directed therapy predicted failure (odds ratio 3.80, P < 0.001). Age, achalasia subtype, myotomy characteristics and post‐POEM endoscopy findings were not predictive. Conclusion: POEM provides durable symptom relief beyond 5 years for achalasia. Higher pre‐POEM symptom burden and prior LOS‐directed interventions are associated with reduced long‐term success.
- 16 August 2026
- Published by Wiley in Internal Medicine Journal
Sustained clinical outcomes at long‐term follow‐up after peroral endoscopic myotomy for achalasia: a multicentre cohort study
Background: Peroral endoscopic myotomy (POEM) is an established treatment for achalasia, achieving >90% short‐term clinical success. However, long‐term durability remains less clear. This study evaluates POEM outcomes beyond 5 years in a multi‐centre cohort. Aims: This study evaluates POEM outcomes beyond 5 years in a multi‐centre cohort. Methods: Patients with achalasia who underwent POEM across four Australian tertiary centres (January 2014–January 2020) were prospectively enrolled. Eckardt scores were recorded pre‐treatment and at multiple intervals up to ≥5 years after POEM. Primary outcome was clinical success at ≥5 years, defined as Eckardt score ≤3 without need for re‐intervention. Secondary outcomes included risk factors for failure and management strategies. Results: Of 221 eligible patients, 153 (69.2%) had ≥5‐year follow‐up data available, with median follow‐up of 6.5 years (interquartile range (IQR) 5.6–7.6). Achalasia subtypes included type I (23.5%), type II (62.1%) and type III (14.4%). Among the patients, 52.3% were treatment‐naïve; prior therapies included laparoscopic Heller myotomy (14.3%), botulinum toxin (17.0%) and pneumatic balloon dilation (30.7%). Clinical success at ≥5 years was observed in 118 (77.1%) patients. Median Eckardt scores improved from 8.0 (IQR 6.0–10.0) before POEM to 0.0 (IQR 0.0–1.0) at 3–6 months, 1.0 (IQR 0.0–2.0) at 2 years and 2.0 (IQR 0.0–3.0) at 5 years. Sustained success was associated with lower baseline Eckardt scores ( P = 0.033). Prior lower oesophageal sphincter (LOS)‐directed therapy predicted failure (odds ratio 3.80, P < 0.001). Age, achalasia subtype, myotomy characteristics and post‐POEM endoscopy findings were not predictive. Conclusion: POEM provides durable symptom relief beyond 5 years for achalasia. Higher pre‐POEM symptom burden and prior LOS‐directed interventions are associated with reduced long‐term success.
- Open Access
- 14 July 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
Global Variability in the Implementation of Gastric Cancer Prevention Guidelines: A Multinational Survey
Background and study aim: Gastric cancer (GC) remains a major cause of cancer-related mortality worldwide. Although international guidelines recommend strategies for screening, diagnosis, and surveillance of gastric premalignant conditions, their implementation in clinical practice remains uncertain. This study aimed to evaluate global endoscopic practices and adherence to GC prevention guidelines. Patients and methods: We conducted a multinational web-based cross-sectional survey between August and September 2025 among endoscopists from 32 countries. A 28-item questionnaire assessed demographics, screening strategies, endoscopic technical practices, pathology infrastructure, H.pylori management, and surveillance policies. The primary outcome was characterization of current practices in GC screening and management of premalignant gastric conditions. Secondary outcomes included variability according to country and experience, and adherence to guidelines. Descriptive statistics, chi-square testing, and the Index of Qualitative Variation assessed heterogeneity. A composite guideline adherence score based on six indicators was calculated and hierarchical clustering identified country-level adherence patterns. Results: A total of 863 physicians participated, most of whom were certified gastroenterologists. Routine H.pylori testing during endoscopy was reported by 73.7% (n=635) of respondents, while access to high-definition endoscopy with virtual chromoendoscopy was available to 58.7% (n=507). Although photo-documentation was widely available (90.4%, n=780), only 40.6% (n=350) consistently documented recommended anatomical sites and 20.4% (n=176) used structured reporting systems. Guideline-based surveillance was reported by 85.7% (n=737) of respondents. Cluster analysis identified three country-level adherence groups with mean scores of approximately 0.83, 0.60, and 0.41. Conclusions: Implementation of GC prevention guidelines varies worldwide. Infrastructure, training, and healthcare organization appear to be key determinants of adherence rather than national GC incidence.
- 14 July 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
Open AccessGlobal Variability in the Implementation of Gastric Cancer Prevention Guidelines: A Multinational Survey
Background and study aim: Gastric cancer (GC) remains a major cause of cancer-related mortality worldwide. Although international guidelines recommend strategies for screening, diagnosis, and surveillance of gastric premalignant conditions, their implementation in clinical practice remains uncertain. This study aimed to evaluate global endoscopic practices and adherence to GC prevention guidelines. Patients and methods: We conducted a multinational web-based cross-sectional survey between August and September 2025 among endoscopists from 32 countries. A 28-item questionnaire assessed demographics, screening strategies, endoscopic technical practices, pathology infrastructure, H.pylori management, and surveillance policies. The primary outcome was characterization of current practices in GC screening and management of premalignant gastric conditions. Secondary outcomes included variability according to country and experience, and adherence to guidelines. Descriptive statistics, chi-square testing, and the Index of Qualitative Variation assessed heterogeneity. A composite guideline adherence score based on six indicators was calculated and hierarchical clustering identified country-level adherence patterns. Results: A total of 863 physicians participated, most of whom were certified gastroenterologists. Routine H.pylori testing during endoscopy was reported by 73.7% (n=635) of respondents, while access to high-definition endoscopy with virtual chromoendoscopy was available to 58.7% (n=507). Although photo-documentation was widely available (90.4%, n=780), only 40.6% (n=350) consistently documented recommended anatomical sites and 20.4% (n=176) used structured reporting systems. Guideline-based surveillance was reported by 85.7% (n=737) of respondents. Cluster analysis identified three country-level adherence groups with mean scores of approximately 0.83, 0.60, and 0.41. Conclusions: Implementation of GC prevention guidelines varies worldwide. Infrastructure, training, and healthcare organization appear to be key determinants of adherence rather than national GC incidence.
- 16 March 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (07) , 719-730
Endoscopic resection-related duodenal strictures: prevalence, risk factors, management, and outcomes
Endoscopic resection (ER) of large (≥15 mm) duodenal laterally spreading lesions (D-LSLs) is now standard of care. Data on prevalence, risk factors, and management of strictures after ER of D-LSL are absent; we sought to evaluate this in a large tertiary referral cohort. A prospective cohort of ER-treated D-LSLs in an expert center was retrospectively analyzed. Strictures were considered “severe” if patients experienced obstructive symptoms, “moderate” if a standard gastroscope (diameter 9.9 mm) could not pass the stenosis, or “mild” if there was resistance on successful passage. When necessary, dilation was performed every 2–4 weeks until scope passage without resistance. Primary outcomes included stricture prevalence, risk factors, and management. Over 193 months until February 2023, 246 lesions in 239 patients were included (median age 70 years [interquartile range (IQR) 63–77]; 51.5% male; median lesion size 35 mm [IQR 22.5–47.5]). Overall, 30 resections (12.2%) resulted in stricture (14 mild [46.7%], 4 moderate [13.3%], and 12 severe [40%]), and 18 (7.3%) required balloon dilation (median 2 sessions [IQR 0–6]). On multivariable analysis, post-ER defect circumference ≥80% was the strongest independent predictor of stricture formation (OR 60.2, 95%CI 17.5–254.2; P < 0.001). Incidence of stricture formation with ER defects of ≥80%, 60%–79%, and <60% was 72.2% (26/36), 12.5% (4/32), and 0% (0/178), respectively. All severe strictures occurred in ER defects ≥80%. ER defect circumference strongly predicted stricture formation following ER of D-LSLs. These findings can be used to guide informed consent and post-procedural care.
- 16 March 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (07) , 719-730
Endoscopic resection-related duodenal strictures: prevalence, risk factors, management, and outcomes
Endoscopic resection (ER) of large (≥15 mm) duodenal laterally spreading lesions (D-LSLs) is now standard of care. Data on prevalence, risk factors, and management of strictures after ER of D-LSL are absent; we sought to evaluate this in a large tertiary referral cohort. A prospective cohort of ER-treated D-LSLs in an expert center was retrospectively analyzed. Strictures were considered “severe” if patients experienced obstructive symptoms, “moderate” if a standard gastroscope (diameter 9.9 mm) could not pass the stenosis, or “mild” if there was resistance on successful passage. When necessary, dilation was performed every 2–4 weeks until scope passage without resistance. Primary outcomes included stricture prevalence, risk factors, and management. Over 193 months until February 2023, 246 lesions in 239 patients were included (median age 70 years [interquartile range (IQR) 63–77]; 51.5% male; median lesion size 35 mm [IQR 22.5–47.5]). Overall, 30 resections (12.2%) resulted in stricture (14 mild [46.7%], 4 moderate [13.3%], and 12 severe [40%]), and 18 (7.3%) required balloon dilation (median 2 sessions [IQR 0–6]). On multivariable analysis, post-ER defect circumference ≥80% was the strongest independent predictor of stricture formation (OR 60.2, 95%CI 17.5–254.2; P < 0.001). Incidence of stricture formation with ER defects of ≥80%, 60%–79%, and <60% was 72.2% (26/36), 12.5% (4/32), and 0% (0/178), respectively. All severe strictures occurred in ER defects ≥80%. ER defect circumference strongly predicted stricture formation following ER of D-LSLs. These findings can be used to guide informed consent and post-procedural care.
- Top Cited Papers
Oncological impact of universal endoscopic submucosal dissection for large Barrett’s cancers
Background: Oncological principles favour en bloc R0 excision for curative endoscopic resection. In Barrett’s neoplasia, endoscopically curable cancers include T1a and selected early T1b disease. Although endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are established treatments, optimal lesion selection remains debated. Objective: To evaluate the oncological impact of two selective resection strategies: (1) prioritising ESD for suspected Barrett’s cancers >15 mm and (2) a historical approach reserving ESD mainly for advanced cancers. Design: Multicentre retrospective observational study comparing an ESD-first strategy (period 2, 2017–2024) with a historical selective ESD approach (period 1, 2004–2016). Lesion allocation was based on endoscopic assessment of invasion in both periods. Outcomes included basal R0 resection, curative resection, recurrence and adverse events. Results: A total of 581 resections were performed in 542 patients (median lesion size 20 mm). Cancer was present in 271 cases (178 T1a and 93 T1b). Period 2 had a higher cancer burden (52.3% vs 34.9%) and greater ESD use (77.1% vs 21.2%). Basal R0 resection improved from 69.7% to 91.2% (p<0.001), with the greatest benefit in T1b lesions (33.3% to 81.9%, p15 mm improves basal R0 resection, reduces recurrence and improves short-term survival for T1b disease, supporting routine ESD for all larger Barrett’s cancers.
Top Cited PapersOncological impact of universal endoscopic submucosal dissection for large Barrett’s cancers
Background: Oncological principles favour en bloc R0 excision for curative endoscopic resection. In Barrett’s neoplasia, endoscopically curable cancers include T1a and selected early T1b disease. Although endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are established treatments, optimal lesion selection remains debated. Objective: To evaluate the oncological impact of two selective resection strategies: (1) prioritising ESD for suspected Barrett’s cancers >15 mm and (2) a historical approach reserving ESD mainly for advanced cancers. Design: Multicentre retrospective observational study comparing an ESD-first strategy (period 2, 2017–2024) with a historical selective ESD approach (period 1, 2004–2016). Lesion allocation was based on endoscopic assessment of invasion in both periods. Outcomes included basal R0 resection, curative resection, recurrence and adverse events. Results: A total of 581 resections were performed in 542 patients (median lesion size 20 mm). Cancer was present in 271 cases (178 T1a and 93 T1b). Period 2 had a higher cancer burden (52.3% vs 34.9%) and greater ESD use (77.1% vs 21.2%). Basal R0 resection improved from 69.7% to 91.2% (p<0.001), with the greatest benefit in T1b lesions (33.3% to 81.9%, p15 mm improves basal R0 resection, reduces recurrence and improves short-term survival for T1b disease, supporting routine ESD for all larger Barrett’s cancers.
- Open Access
- 13 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP)
Predictive Accuracy of Optical Evaluation for High-Risk Serrated Lesions and the Impact of a Brief Educational Intervention
Background Real-time characterization of advanced lesions during colonoscopy informs the therapeutic approach. Sessile serrated lesions with dysplasia are a subgroup of advanced lesions that are difficult to recognize and accurately characterize. The ability of expert endoscopists to recognize these lesions is unknown; moreover, the impact of a simple training module on subsequent performance is of interest. Methods Seventy high-quality images were selected from a database of large sessile and flat polyps. Histopathology was used as the gold standard. The images were presented in randomized order to expert endoscopists and trainees. Participants were asked to predict the underlying histology. Subsequently, an educational module was delivered, and participants were asked to repeat the test using the same images in a different randomized order. Results Thirty-seven participants were included: 16 trainees and 21 experts. Baseline predictive accuracy for SSL-D was only 24.0% across the group; 18.3% for trainees and 28.2% for experts. This improved significantly, regardless of experience level, after the educational module to 69.7% (p < 0.001) for the whole cohort; 67.5% for trainees and 71.4% for experts. Before training, SSL-D was incorrectly identified as tubular adenomas or tubulovillous adenomas in 40% of cases. Posttraining, this reduced significantly to 7.6% (p < 0.001) for all participants. For experts, this decreased to 7.0% (p < 0.001) and trainees to 8.3% (p < 0.001). Conclusion SSL-D lesions are underdiagnosed by both expert and trainee endoscopists. A brief educational intervention can significantly improve the predictive accuracy and performance of experts and trainees.
- 13 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP)
Open AccessPredictive Accuracy of Optical Evaluation for High-Risk Serrated Lesions and the Impact of a Brief Educational Intervention
Background Real-time characterization of advanced lesions during colonoscopy informs the therapeutic approach. Sessile serrated lesions with dysplasia are a subgroup of advanced lesions that are difficult to recognize and accurately characterize. The ability of expert endoscopists to recognize these lesions is unknown; moreover, the impact of a simple training module on subsequent performance is of interest. Methods Seventy high-quality images were selected from a database of large sessile and flat polyps. Histopathology was used as the gold standard. The images were presented in randomized order to expert endoscopists and trainees. Participants were asked to predict the underlying histology. Subsequently, an educational module was delivered, and participants were asked to repeat the test using the same images in a different randomized order. Results Thirty-seven participants were included: 16 trainees and 21 experts. Baseline predictive accuracy for SSL-D was only 24.0% across the group; 18.3% for trainees and 28.2% for experts. This improved significantly, regardless of experience level, after the educational module to 69.7% (p < 0.001) for the whole cohort; 67.5% for trainees and 71.4% for experts. Before training, SSL-D was incorrectly identified as tubular adenomas or tubulovillous adenomas in 40% of cases. Posttraining, this reduced significantly to 7.6% (p < 0.001) for all participants. For experts, this decreased to 7.0% (p < 0.001) and trainees to 8.3% (p < 0.001). Conclusion SSL-D lesions are underdiagnosed by both expert and trainee endoscopists. A brief educational intervention can significantly improve the predictive accuracy and performance of experts and trainees.
- Open Access
- 13 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP)
Real-world practices and barriers in endoscopic submucosal dissection training: International comprehensive survey
Endoscopic submucosal dissection (ESD) enables curative resection of superficial gastrointestinal neoplasia but requires structured training. Although European Society of Gastrointestinal Endoscopy (ESGE)/American Society for Gastrointestinal Endoscopy (ASGE) curricula exist, real-world practices and barriers remain unclear. We conducted an anonymous web-based survey (April–July 2025) with 55 items assessing training opportunities, barriers, curriculum adherence, and quality metrics, stratified by role and annual ESD volume. We received 288 responses (137 trainees, 151 trainers) from 39 countries across five geographic macro-areas. Nearly half (47.2%) had undertaken structured training, but only 46.5% fulfilled ESGE/ASGE curricula, with marked variation by center volume (69.6% in high-volume vs 26.8% in low-volume, P < 0.001). Lack of access to training models was reported by 46.5% overall, more frequently in low-volume centers. In vivo human training, animal models, and intensive courses were rated highest, whereas lack of simulators, fellowship costs, and limited time were leading barriers. Quality monitoring was reported in 62.5% of centers, prioritizing R0 and en bloc resection rates over procedure speed. Trainees valued traction and underwater techniques more than trainers. Regional differences were pronounced: North-West Europe and Asia-Pacific concentrated high-volume centers and greater curriculum adherence, whereas Africa/Middle East and South-East Europe faced resource and financial constraints. This international survey reveals substantial disparities in ESD training and calls for coordinated efforts to improve access to structured curricula, mentorship, and affordable training models.
- 13 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP)
Open AccessReal-world practices and barriers in endoscopic submucosal dissection training: International comprehensive survey
Endoscopic submucosal dissection (ESD) enables curative resection of superficial gastrointestinal neoplasia but requires structured training. Although European Society of Gastrointestinal Endoscopy (ESGE)/American Society for Gastrointestinal Endoscopy (ASGE) curricula exist, real-world practices and barriers remain unclear. We conducted an anonymous web-based survey (April–July 2025) with 55 items assessing training opportunities, barriers, curriculum adherence, and quality metrics, stratified by role and annual ESD volume. We received 288 responses (137 trainees, 151 trainers) from 39 countries across five geographic macro-areas. Nearly half (47.2%) had undertaken structured training, but only 46.5% fulfilled ESGE/ASGE curricula, with marked variation by center volume (69.6% in high-volume vs 26.8% in low-volume, P < 0.001). Lack of access to training models was reported by 46.5% overall, more frequently in low-volume centers. In vivo human training, animal models, and intensive courses were rated highest, whereas lack of simulators, fellowship costs, and limited time were leading barriers. Quality monitoring was reported in 62.5% of centers, prioritizing R0 and en bloc resection rates over procedure speed. Trainees valued traction and underwater techniques more than trainers. Regional differences were pronounced: North-West Europe and Asia-Pacific concentrated high-volume centers and greater curriculum adherence, whereas Africa/Middle East and South-East Europe faced resource and financial constraints. This international survey reveals substantial disparities in ESD training and calls for coordinated efforts to improve access to structured curricula, mentorship, and affordable training models.